1. Home
  2. IPWR vs NRSN Comparison

IPWR vs NRSN Comparison

Compare IPWR & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

HOLD

Current Price

$3.47

Market Cap

26.3M

Sector

Industrials

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.84

Market Cap

26.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPWR
NRSN
Founded
2007
2017
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
26.4M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
IPWR
NRSN
Price
$3.47
$0.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$10.75
$14.00
AVG Volume (30 Days)
58.1K
366.2K
Earning Date
11-13-2025
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,136.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3,233.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$0.68
52 Week High
$8.62
$2.60

Technical Indicators

Market Signals
Indicator
IPWR
NRSN
Relative Strength Index (RSI) 46.46 46.61
Support Level $2.76 $0.68
Resistance Level $3.36 $0.91
Average True Range (ATR) 0.31 0.07
MACD 0.05 0.01
Stochastic Oscillator 60.40 71.22

Price Performance

Historical Comparison
IPWR
NRSN

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: